{"transactions":[{"id":1471886,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T16:07:52.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 20, 2025 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":32500,"derivative":{"exercise_price":4.05,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001662579-24-000057","document":"wk-form4_1719000465.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000166257924000057/wk-form4_1719000465.xml","form_type":"4"}},{"id":1813463,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-08-08T23:46:34.000Z","date":"2022-11-21","kind":"gift","planned":false,"acquired":false,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":52729,"source":{"system":"sec-edgar","filing":"0000721371-23-000052","document":"wf-form5_169153838293516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137123000052/wf-form5_169153838293516.xml","form_type":"5"}},{"id":1851797,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T16:24:21.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2024 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date."}],"balance_after":26000,"derivative":{"exercise_price":3.61,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001662579-23-000060","document":"wk-form4_1686947050.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000166257923000060/wk-form4_1686947050.xml","form_type":"4"}},{"id":2120634,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-11-10T21:33:28.000Z","date":"2022-11-09","kind":"grant","acquired":true,"shares":2308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders."}],"balance_after":53929,"source":{"system":"sec-edgar","filing":"0000721371-22-000162","document":"wf-form4_166811599108843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137122000162/wf-form4_166811599108843.xml","form_type":"4"}},{"id":2222917,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-23T16:15:14.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 22, 2023 and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":23500,"derivative":{"exercise_price":6.06,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001209191-22-038861","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000120919122038861/doc4.xml","form_type":"4"}},{"id":2513942,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-15T13:11:43.000Z","date":"2021-11-11","kind":"grant","acquired":true,"shares":3709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on November 11, 2022, except if the 2022 Annual Meeting of Shareholders is prior to November 11, 2022, then the restricted share units will vest on the date of the 2022 Annual Meeting of Shareholders."}],"balance_after":51621,"source":{"system":"sec-edgar","filing":"0000721371-21-000134","document":"wf-form4_163698188805846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137121000134/wf-form4_163698188805846.xml","form_type":"4"}},{"id":2663250,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T16:16:13.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":23500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in full upon the earlier to occur of (i) June 15, 2022 and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":23500,"derivative":{"exercise_price":37.66,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":23500},"source":{"system":"sec-edgar","filing":"0001209191-21-041421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000120919121041421/doc4.xml","form_type":"4"}},{"id":2987540,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-11-10T21:39:53.000Z","date":"2020-11-09","kind":"grant","acquired":true,"shares":3339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders."}],"balance_after":47912,"source":{"system":"sec-edgar","filing":"0000721371-20-000156","document":"wf-form4_160504438095364.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137120000156/wf-form4_160504438095364.xml","form_type":"4"}},{"id":3011545,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-10-06T21:27:00.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":2128571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":252394},"source":{"system":"sec-edgar","filing":"0000899243-20-027695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000089924320027695/doc4.xml","form_type":"4"}},{"id":3011544,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-10-06T21:27:00.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":237148},"source":{"system":"sec-edgar","filing":"0000899243-20-027695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000089924320027695/doc4.xml","form_type":"4"}},{"id":3011543,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T21:27:00.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":252394,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."}],"balance_after":489542,"source":{"system":"sec-edgar","filing":"0000899243-20-027695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000089924320027695/doc4.xml","form_type":"4"}},{"id":3011542,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T21:27:00.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":237148,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date."}],"balance_after":237148,"source":{"system":"sec-edgar","filing":"0000899243-20-027695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000089924320027695/doc4.xml","form_type":"4"}},{"id":3012847,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-05T21:00:16.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable upon the earlier to occur of (i) October 1, 2021, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":17786,"derivative":{"exercise_price":19,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0000899243-20-027445","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000089924320027445/doc4.xml","form_type":"4"}},{"id":3018392,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:10:44.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":38.09,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-010059","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020010059/edgar.xml","form_type":"4"}},{"id":3018391,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:10:44.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":12.64,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-010059","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020010059/edgar.xml","form_type":"4"}},{"id":3018390,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:10:44.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":8855,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":22.3,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":8855},"source":{"system":"sec-edgar","filing":"0001179110-20-010059","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020010059/edgar.xml","form_type":"4"}},{"id":3018389,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:10:44.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":11207,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":17.2,"expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":11207},"source":{"system":"sec-edgar","filing":"0001179110-20-010059","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020010059/edgar.xml","form_type":"4"}},{"id":3018388,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:10:44.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":11000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":10.97,"expiration_date":"2026-06-23","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001179110-20-010059","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020010059/edgar.xml","form_type":"4"}},{"id":3018387,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:10:44.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":17750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":22.18,"expiration_date":"2025-06-10","underlying":"Common Stock","underlying_shares":17750},"source":{"system":"sec-edgar","filing":"0001179110-20-010059","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020010059/edgar.xml","form_type":"4"}},{"id":3018386,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:10:44.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":17750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":13.16,"expiration_date":"2024-06-12","underlying":"Common Stock","underlying_shares":17750},"source":{"system":"sec-edgar","filing":"0001179110-20-010059","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020010059/edgar.xml","form_type":"4"}},{"id":3018385,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:10:44.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":17750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":14.42,"expiration_date":"2023-06-11","underlying":"Common Stock","underlying_shares":17750},"source":{"system":"sec-edgar","filing":"0001179110-20-010059","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020010059/edgar.xml","form_type":"4"}},{"id":3018384,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:10:44.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":17750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":14.87,"expiration_date":"2022-06-13","underlying":"Common Stock","underlying_shares":17750},"source":{"system":"sec-edgar","filing":"0001179110-20-010059","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020010059/edgar.xml","form_type":"4"}},{"id":3018383,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T17:10:44.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":17750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":18.19,"expiration_date":"2021-06-14","underlying":"Common Stock","underlying_shares":17750},"source":{"system":"sec-edgar","filing":"0001179110-20-010059","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020010059/edgar.xml","form_type":"4"}},{"id":3018382,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T17:10:44.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":41844,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by that certain Agreement and Plan of Merger, dated as of August 19, 2020 (the \"Merger Agreement\"), by and among Johnson & Johnson, Vigor Sub, Inc. (\"Merger Sub\") and the Issuer, including the completion of a tender offer to purchase all of the outstanding shares of Issuer common stock at a price of $52.50 per share in cash, without interest, less any required withholding taxes (the \"Offer Price\"), and the consummation of the merger (the \"Merger\") between the Issuer and Merger Sub on October 1, 2020.  Pursuant to the Merger Agreement, as of the effective time of the Merger (the \"Effective Time\"), each outstanding share of Issuer common stock was cancelled in exchange for the right to receive an amount equal to the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-20-010059","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020010059/edgar.xml","form_type":"4"}},{"id":3100741,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-24T17:47:18.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan.  The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Mr. Downey's continued service to the Company."}],"balance_after":25000,"derivative":{"exercise_price":38.09,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-007758","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020007758/edgar.xml","form_type":"4"}},{"id":3116050,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-09T17:51:02.000Z","date":"2020-06-05","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested as to 25% of the underlying shares at the end of each three-month period following the June 10, 2010 grant date, such that the option was fully vested on June 10, 2011."}],"balance_after":0,"derivative":{"exercise_price":12.34,"expiration_date":"2020-06-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001179110-20-007144","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020007144/edgar.xml","form_type":"4"}},{"id":3116049,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T17:51:02.000Z","date":"2020-06-05","kind":"tax_withholding","acquired":false,"shares":5746,"price":32.21,"value":185078.66,"ownership":{"direct":true},"balance_after":41844,"source":{"system":"sec-edgar","filing":"0001179110-20-007144","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020007144/edgar.xml","form_type":"4"}},{"id":3116048,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-09T17:51:02.000Z","date":"2020-06-05","kind":"exercise","acquired":true,"shares":15000,"price":12.34,"value":185100.0,"ownership":{"direct":true},"balance_after":47590,"source":{"system":"sec-edgar","filing":"0001179110-20-007144","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911020007144/edgar.xml","form_type":"4"}},{"id":3373762,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-11-13T21:18:17.000Z","date":"2019-11-12","kind":"grant","acquired":true,"shares":3424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on November 12, 2020, except if the 2020 Annual Meeting of Shareholders is prior to November 12, 2020, then the restricted share units will vest on the date of the 2020 Annual Meeting of Shareholders."}],"balance_after":44573,"source":{"system":"sec-edgar","filing":"0000721371-19-000148","document":"wf-form4_157367987960097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137119000148/wf-form4_157367987960097.xml","form_type":"4"}},{"id":3481113,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-21T16:17:01.000Z","date":"2019-06-20","kind":"exercise","acquired":false,"shares":4356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4356},"source":{"system":"sec-edgar","filing":"0001179110-19-008026","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911019008026/edgar.xml","form_type":"4"}},{"id":3481112,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T16:17:01.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan.  The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Mr. Downey's continued service to the Company."}],"balance_after":25000,"derivative":{"exercise_price":12.64,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-19-008026","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911019008026/edgar.xml","form_type":"4"}},{"id":3481111,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-21T16:17:01.000Z","date":"2019-06-20","kind":"exercise","acquired":true,"shares":4356,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32590,"source":{"system":"sec-edgar","filing":"0001179110-19-008026","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911019008026/edgar.xml","form_type":"4"}},{"id":3492635,"issuer":{"id":154249,"kind":"organization","name":"MELINTA THERAPEUTICS, INC. /NEW/","symbol":"MLNT"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Melinta Restricted Stock Units","published_at":"2019-06-12T13:37:37.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units will vest on the day before the 2020 Annual Meeting of Shareholders, or approximately June 7, 2020, subject to continued service with the Issuer through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units will vest on the day before the 2020 Annual Meeting of Shareholders, or approximately June 7, 2020, subject to continued service with the Issuer through the applicable vesting date."}],"balance_after":30000,"derivative":{"exercise_price":0,"underlying":"Melinta Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001461993-19-000032","document":"wf-form4_156036104257729.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1461993/000146199319000032/wf-form4_156036104257729.xml","form_type":"4"}},{"id":3584441,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-20T16:57:28.000Z","date":"2019-03-18","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested as to 8.33% of the underlying shares at the end of each three-month period following the June 11, 2009 grant date, such that the option was fully vested on June 11, 2012."}],"balance_after":7000,"derivative":{"exercise_price":8.85,"expiration_date":"2019-06-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001179110-19-004104","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911019004104/edgar.xml","form_type":"4"}},{"id":3584440,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-20T16:57:28.000Z","date":"2019-03-18","kind":"sale","acquired":false,"shares":13000,"price":14.51,"value":188630.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $14.50 to $14.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":28234,"source":{"system":"sec-edgar","filing":"0001179110-19-004104","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911019004104/edgar.xml","form_type":"4"}},{"id":3584439,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-20T16:57:28.000Z","date":"2019-03-18","kind":"exercise","acquired":true,"shares":20000,"price":8.85,"value":177000.0,"ownership":{"direct":true},"balance_after":41234,"source":{"system":"sec-edgar","filing":"0001179110-19-004104","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911019004104/edgar.xml","form_type":"4"}},{"id":3745748,"issuer":{"id":154249,"kind":"organization","name":"MELINTA THERAPEUTICS, INC. /NEW/","symbol":"MLNT"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-03T17:36:21.000Z","date":"2018-11-30","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares underlying the stock option will vest and become exercisable on October 31, 2019.  The remainder will vest and become exercisable in substantially equal monthly installments during the two year period commencing on October 31, 2019."}],"balance_after":25000,"derivative":{"exercise_price":2.12,"expiration_date":"2028-10-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-18-029964","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1461993/000089924318029964/doc4.xml","form_type":"4"}},{"id":3768928,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2018-11-13T22:17:19.000Z","date":"2018-11-09","kind":"grant","acquired":true,"shares":3164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on November 9, 2019, except if the 2019 Annual Meeting of Shareholders is prior to November 9, 2019, then the restricted share units will vest on the date of the 2019 Annual Meeting of Shareholders."}],"balance_after":41149,"source":{"system":"sec-edgar","filing":"0000721371-18-000117","document":"wf-form4_154214741790585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137118000117/wf-form4_154214741790585.xml","form_type":"4"}},{"id":3884823,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-06-22T18:02:00.000Z","date":"2018-06-20","kind":"exercise","acquired":false,"shares":5734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5734},"source":{"system":"sec-edgar","filing":"0001179110-18-008970","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911018008970/edgar.xml","form_type":"4"}},{"id":3884822,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-22T18:02:00.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":4356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of MNTA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents 4,356 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Mr. Downey's continued service to the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents 4,356 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Mr. Downey's continued service to the Company."}],"balance_after":4356,"derivative":{"underlying":"Common Stock","underlying_shares":4356},"source":{"system":"sec-edgar","filing":"0001179110-18-008970","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911018008970/edgar.xml","form_type":"4"}},{"id":3884821,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T18:02:00.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":8855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan.  The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Mr. Downey's continued service to the Company."}],"balance_after":8855,"derivative":{"exercise_price":22.3,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":8855},"source":{"system":"sec-edgar","filing":"0001179110-18-008970","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911018008970/edgar.xml","form_type":"4"}},{"id":3884820,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-22T18:02:00.000Z","date":"2018-06-20","kind":"exercise","acquired":true,"shares":5734,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21234,"source":{"system":"sec-edgar","filing":"0001179110-18-008970","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911018008970/edgar.xml","form_type":"4"}},{"id":4168419,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2017-11-09T22:28:42.000Z","date":"2017-11-08","kind":"grant","acquired":true,"shares":2623,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on November 8, 2018, except if the 2018 Annual Meeting of Shareholders is prior to November 8, 2018, then restricted share units will vest on the date of the 2018 Annual Meeting of Shareholders."}],"balance_after":37985,"source":{"system":"sec-edgar","filing":"0000721371-17-000153","document":"wf-form4_151026650886565.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137117000153/wf-form4_151026650886565.xml","form_type":"4"}},{"id":4274409,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-22T16:15:24.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":5734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of MNTA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents 5,734 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Mr. Downey's continued service to the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents 5,734 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Mr. Downey's continued service to the Company."}],"balance_after":5734,"derivative":{"underlying":"Common Stock","underlying_shares":5734},"source":{"system":"sec-edgar","filing":"0001179110-17-009454","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911017009454/edgar.xml","form_type":"4"}},{"id":4274408,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-22T16:15:24.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":11207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan.  The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Mr. Downey's continued service to the Company."}],"balance_after":11207,"derivative":{"exercise_price":17.2,"expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":11207},"source":{"system":"sec-edgar","filing":"0001179110-17-009454","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1237257/000117911017009454/edgar.xml","form_type":"4"}},{"id":4566220,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":89645,"kind":"person","name":"DOWNEY BRUCE","position":1,"cik":"0001237257","reported_name":"DOWNEY BRUCE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2016-11-07T13:21:14.000Z","date":"2016-11-03","kind":"grant","acquired":true,"shares":2447,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on November 3, 2017, except if the 2017 Annual Meeting of Shareholders is prior to November 3, 2017, then the restricted share units will vest on the date of the 2017 Annual Meeting of Shareholders."}],"balance_after":35362,"source":{"system":"sec-edgar","filing":"0000721371-16-000347","document":"wf-form4_147852486150264.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137116000347/wf-form4_147852486150264.xml","form_type":"4"}}]}